We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.38%
2 Healthcare 7.46%
3 Consumer Discretionary 5.14%
4 Industrials 5.11%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGC icon
6051
BGC Group
BGC
$5.68B
-2,640,003
Closed -$13.8M
BGY icon
6052
BlackRock Enhanced International Dividend Trust
BGY
$530M
-53,722
Closed -$290K
BHK icon
6053
BlackRock Core Bond Trust
BHK
$647M
-12,915
Closed -$140K
BIO icon
6054
CALL
Bio-Rad Laboratories Class A
BIO
$10.2B
-25,000
Closed -$12M
BKSY icon
6055
BlackSky Technology
BKSY
$1.05B
-92,952
Closed -$1.11M
BLCO icon
6056
CALL
Bausch + Lomb
BLCO
$6.19B
-80,000
Closed -$1.39M
BLUE
6057
CALL
DELISTED
bluebird bio
BLUE
-12,385
Closed -$788K
BLUE
6058
DELISTED
bluebird bio
BLUE
-80,958
Closed -$5.15M
BLZE icon
6059
Backblaze
BLZE
$963M
-43,442
Closed -$219K
BMRN icon
6060
PUT
BioMarin Pharmaceuticals
BMRN
$12.6B
-125,300
Closed -$12.2M
BN icon
6061
Brookfield
BN
$93.7B
-183,857
Closed -$3.99M
BOE icon
6062
BlackRock Enhanced Global Dividend Trust
BOE
$690M
-16,885
Closed -$168K
BPRN icon
6063
Princeton Bancorp
BPRN
$289M
-49,501
Closed -$1.57M
BRK.A icon
6064
Berkshire Hathaway Class A
BRK.A
$1.08T
-35
Closed -$16.3M
BRKR icon
6065
CALL
Bruker
BRKR
$8.68B
-10,000
Closed -$788K
BRNS
6066
Barinthus Biotherapeutics
BRNS
$24.6M
-41,945
Closed -$94K
BTG icon
6067
CALL
B2Gold
BTG
$7.56B
-7,300,000
Closed -$28.8M
BTM
6068
DELISTED
Bitcoin Depot
BTM
-11,786
Closed -$842K
BTMWW
6069
CALL
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
-82,500
Closed -$3K
BTZ icon
6070
BlackRock Credit Allocation Income Trust
BTZ
$942M
-19,521
Closed -$201K
BTU icon
6071
PUT
Peabody Energy
BTU
$3.4B
-54,500
Closed -$1.4M
BUD icon
6072
PUT
AB InBev
BUD
$156B
-36,500
Closed -$2.44M
BUSE icon
6073
First Busey Corp
BUSE
$2.5B
-164,527
Closed -$3.35M
BVN icon
6074
CALL
Compañía de Minas Buenaventura
BVN
$8.94B
-77,000
Closed -$630K
BVN icon
6075
PUT
Compañía de Minas Buenaventura
BVN
$8.94B
-77,000
Closed -$630K

Similar funds

Israel Englander's Q2 2023 Portfolio in Review

As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
  • Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.